TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index.
Abstract
Sequence variations in the triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to an increased risk for neurodegenerative disorders such as Alzheimer's disease and frontotemporal lobar degeneration. In the brain, TREM2 is predominantly expressed in microglia. Several disease-associated TREM2 variants result in a loss of function by reducing microglial phagocytosis, impairing lipid sensing, preventing binding of lipoproteins and affecting shielding of amyloid plaques. We here investigate the consequences of TREM2 loss of function on the microglia transcriptome. Among the differentially expressed messenger RNAs in wild-type and Trem2-/- microglia, gene clusters are identified which represent gene functions in chemotaxis, migration and mobility. Functional analyses confirm that loss of TREM2 impairs appropriate microglial responses to injury and signals that normally evoke chemotaxis on multiple levels. In an ex vivo organotypic brain slice assay, absence of TREM2 reduces the distance migrated by microglia. Moreover, migration towards defined chemo-attractants is reduced upon ablation of TREM2 and can be rescued by TREM2 re-expression. In vivo, microglia lacking TREM2 migrate less towards injected apoptotic neurons, and outgrowth of microglial processes towards sites of laser-induced focal CNS damage in the somatosensory cortex is slowed. The apparent lack of chemotactic stimulation upon depletion of TREM2 is consistent with a stable expression profile of genes characterizing the homoeostatic signature of microglia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2-mediated signaling is known to inhibit the transition of microglia to a more Disease-Associated Microglia (DAM) state characterized by enhanced migration, chemotaxis, and phagocytosis [44,45].”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, lack of Trem2 reduces chemotaxis and phagocytosis of microglia (54, 55).”
From Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis (2021) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microglia with TREM2 loss-of-function cannot transition to the DAM state and are locked in a homeostatic state, in which they no longer respond normally to pathological challenges [34].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“compelling evidence suggesting that TREM2 can regulate microglia phagocytic activity [44,45]”
From TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo (2023) · cites this paper as [45]
The cited source says what the claim attributes to it.
In the citing paper
“TREM2 is a cell-surface receptor of the immunoglobulin superfamily implicated in a variety of microglial functions, such as phagocytosis, chemotaxis and survival21–23.”
From PLCγ2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages (2021) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 2×
“The migration distance was measured using Fiji [65] by drawing a line between the migrated cell and the slice culture border.”
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · cited 1×
“However, the most commonly shared pathological principle of basically all neurodegenerative diseases and many other neurological disorders is gliosis associated with an inflammatory response [4].”
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“In the WT-and Trem2-deficient offspring, we induced a focal CNS damage in the somatosensory cortex using a focussed laser beam [45 – 47] and acquired time-lapse images of the microglial response using in vivo two-photon microscopy (Fig 5A).”
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1×
“Furthermore, for several neurodegenerative diseases, evidence exists that soluble oligomers, which may be rather stable intermediates of the aggregation process of amyloidogenic proteins, are the executers of neurotoxicity [2].”
Self-citationSynaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244 · cited 1×
“Microglia are the resident macrophages of the central nervous system and play a pivotal role in synaptic pruning and apoptotic cell clearance during development of the nervous system [51 – 56].”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Kettenmann, H., Hanisch, U.-K., Noda, M., & Verkhratsky, A. (2011) · Physiological Reviews · doi:10.1152/physrev.00011.2010 · Cited by 3,547 · cited 1×
“As the innate immune cells of the brain, microglia are the first cells to respond to neuronal damage [16,41].”
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Cited by
Items 101–200 of 355
Targeting Microglia in Alzheimer’s Disease: Pathogenesis and Potential Therapeutic Strategies
Sun, Z., Zhang, X., So, K.-F., Jiang, W., & Chiu, K. (2024) · Biomolecules · doi:10.3390/biom14070833 · Cited by 71
“Interestingly, this microglial subtype exhibits reduced responsiveness to TGF β signaling [28] and exerts a protective role in the initial response to neuronal damage [29], particularly in aged brains and neurodegenerative diseases, such as AD, multiple sclerosis (MS), and ALS [27].”
BackgroundTrem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice
Jadhav, V. S., Lin, P. B. C., Pennington, T., Di Prisco, G. V., Jannu, A. J., Xu, G., Moutinho, M., Zhang, J., Atwood, B. K., Puntambekar, S. S., et al. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00409-0 · Cited by 70
Chen, Y., Lad, E. M., Mathew, R., Shiraki, N., Littleton, S., Chen, Y., Hou, J., Schlepckow, K., Degan, S., Chew, L. A., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231011 · Cited by 76
“S3, C and D), suggesting that Trem2 mediates migration of microglia to the subretinal space (Mazaheri et al., 2017; Wang et al., 2015; Zheng et al., 2017).”
BackgroundSelf-citationMicroglia, Trem2, and Neurodegeneration
Shi, Q., Gutierrez, R. A., & Bhat, M. A. (2025) · The Neuroscientist · doi:10.1177/10738584241254118 · Cited by 69
“Low-level TREM2 signaling in these cells may aid in the basal phagocytic activity and the processing of apoptotic cells, thereby preventing unnecessary immune activation and maintaining CNS homeostasis (Mazaheri and others 2017; McQuade and others 2020).”
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Fitz, N. F., Wolfe, C. M., Playso, B. E., Biedrzycki, R. J., Lu, Y., Nam, K. N., Lefterov, I., & Koldamova, R. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00394-4 · Cited by 68
“We found no change in a few genes, previously found downregulated in Trem2 mice, namely Axl, Csf1, and Spp1 [19, 26, 41, 60].”
BackgroundRen, S., Yao, W., Tambini, M. D., Yin, T., Norris, K. A., & D'Adamio, L. (2020) · eLife · doi:10.7554/elife.57513 · Cited by 68
Synaptic pruning of murine adult-born neurons by microglia depends on phosphatidylserine
Kurematsu, C., Sawada, M., Ohmuraya, M., Tanaka, M., Kuboyama, K., Ogino, T., Matsumoto, M., Oishi, H., Inada, H., Ishido, Y., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20202304 · Cited by 67
Błaszczyk, J. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010543 · Cited by 86
O’Keeffe, M., Booker, S. A., Walsh, D. A., Li, M., Henley, C., de Oliveira, L. S., Liu, M., Wang, X., Banqueri, M., Ridley, K., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01833-x · Cited by 72
“Trem2 -deficient microglia also have altered morphology and responses 13,34 .”
Ohara, T., Hata, J., Tanaka, M., Honda, T., Yamakage, H., Yoshida, D., Inoue, T., Hirakawa, Y., Kusakabe, T., Shibata, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25385 · Cited by 69
Uncovering Disease Mechanisms in a Novel Mouse Model Expressing Humanized APOEε4 and Trem2*R47H
Kotredes, K. P., Oblak, A., Pandey, R. S., Lin, P. B.-C., Garceau, D., Williams, H., Uyar, A., O’Rourke, R., O’Rourke, S., Ingraham, C., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.735524 · Cited by 66
“Single nucleotide polymorphisms (SNP) found in TREM2 have been shown to regulate microglial function (Painter et al., 2015; Krasemann et al., 2017; Mazaheri et al., 2017), the most widely studied being the R47H missense mutation in exon 2.”
BackgroundMicroglia gone awry: linking immunometabolism to neurodegeneration
Afridi, R., Lee, W.-H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00246 · Cited by 64
“Trem2 regulates important microglial functions, including migration, survival, chemotaxis, synaptic pruning, and proliferation (Kleinberger et al., 2014, 2017; Mazaheri et al., 2017; Filipello et al., 2018).”
BackgroundWoollacott, I. O. C., Nicholas, J. M., Heslegrave, A., Heller, C., Foiani, M. S., Dick, K. M., Russell, L. L., Paterson, R. W., Keshavan, A., Fox, N. C., et al. (2018) · Alzheimer's Research & Therapy · doi:10.1186/s13195-018-0405-8 · Cited by 62
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Casali, B. T., & Reed-Geaghan, E. G. (2021) · Cells · doi:10.3390/cells10040957 · Cited by 78
“profile, and fail to migrate to apoptotic or injured neurons [59].”
BackgroundInfluentialZambusi, A., Novoselc, K. T., Hutten, S., Kalpazidou, S., Koupourtidou, C., Schieweck, R., Aschenbroich, S., da Silva, L. A. G., Yazgili, A. S., van Bebber, F., et al. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01199-y · Cited by 65
Wang, M., Tang, G., Zhou, C., Guo, H., Hu, Z., Hu, Q., & Li, G. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110387 · Cited by 66
Hall-Roberts, H., Agarwal, D., Obst, J., Smith, T. B., Monzón-Sandoval, J., Di Daniel, E., Webber, C., James, W. S., Mead, E., Davis, J. B., et al. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00709-z · Cited by 62
“Our study is consistent with two mouse studies that demonstrated enrichment of pathways relating to inflammatory and cytokine responses, and chemotactic motility [45, 73].”
ResultSecretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Lichtenthaler, S. F., Tschirner, S. K., & Steiner, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.003 · Cited by 60
Dhandapani, R., Neri, M., Bernhard, M., Brzak, I., Schweizer, T., Rudin, S., Joller, S., Berth, R., Kernen, J., Neuhaus, A., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110883 · Cited by 60
Karahan, H., Smith, D. C., Kim, B., Dabin, L. C., Al-Amin, M. M., Wijeratne, H. R. S., Pennington, T., Viana di Prisco, G., McCord, B., Lin, P. B.-C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3954 · Cited by 53
Gervois, P., & Lambrichts, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01668 · Cited by 57
“with the stroke lesion in TREM2 KO mice is due to the reduced chemotactic capacity in KO mice, which is supported by a previous study that reports a reduced microglial recruitment to sites of laser-induced neuronal injury in TREM2 KO mice (81).”
ResultThe G protein-coupled receptor GPR34 – The past 20 years of a grownup
Schöneberg, T., Meister, J., Knierim, A. B., & Schulz, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.04.008 · Cited by 54
Microglia express ABI3 in the brains of Alzheimer's disease and Nasu-Hakola disease
Satoh, J.-I., Kino, Y., Yanaizu, M., Tosaki, Y., Sakai, K., Ishida, T., & Saito, Y. (2017) · Intractable & Rare Diseases Research · doi:10.5582/irdr.2017.01073 · Cited by 55
Reich, M., Paris, I., Ebeling, M., Dahm, N., Schweitzer, C., Reinhardt, D., Schmucki, R., Prasad, M., Köchl, F., Leist, M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617860 · Cited by 49
A Tale of Two Genes: Microglial Apoe and Trem2
Pimenova, A. A., Marcora, E. M., & Goate, A. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.015 · Cited by 55
“…result in microglia that are impaired with respect to essential functions, including phagocytosis, chemotaxis, proliferation, survival, and an overall beneficial adaptive response to brain tissue damage that accumulates in aging and neurodegeneration (Mazaheri et al., 2017; Wang et al., 2015).”
BackgroundDirect and indirect effects of lipids on microglia function
Leyrolle, Q., Layé, S., & Nadjar, A. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134348 · Cited by 50
Wyatt-Johnson, S. K., & Brutkiewicz, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.592359 · Cited by 50
“In models of neuronal injury, Trigger receptors expressed on myeloid cells 2 (Trem2) depletion in microglia limits their ability to migrate toward injured neurons (Mazaheri et al., 2017).”
BackgroundPal, A., Rani, I., Pawar, A. T., Picozza, M., Rongioletti, M. C. A., & Squitti, R. (2021) · Biomolecules · doi:10.3390/biom11111598 · Cited by 50
“Murine studies have also indicated that mutation in the TREM2 gene, expressed by microglia in the CNS, interferes with Aβ clearance and increases tau hyperphosphorylation due to the reduced phagocytic activity of microglia cells [33,34].”
BackgroundPenney, J., Ralvenius, W. T., Loon, A., Cerit, O., Dileep, V., Milo, B., Pao, P., Woolf, H., & Tsai, L. (2024) · Glia · doi:10.1002/glia.24485 · Cited by 52
“Impaired microglial responses to laser-induced injury have been reported in the brains of TREM2 heterozygous and homozygous KO mice (Mazaheri et al., 2017; Sayed et al., 2018).”
BackgroundKoupourtidou, C., Schwarz, V., Aliee, H., Frerich, S., Fischer-Sternjak, J., Bocchi, R., Simon-Ebert, T., Bai, X., Sirko, S., Kirchhoff, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46625-w · Cited by 48
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Muth, C., Hartmann, A., Sepulveda-Falla, D., Glatzel, M., & Krasemann, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00181 · Cited by 48
Self-citationThe night’s watch: Exploring how sleep protects against neurodegeneration
Parhizkar, S., & Holtzman, D. M. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.004 · Cited by 57
Rong, Z., Cheng, B., Zhong, L., Ye, X., Li, X., Jia, L., Li, Y., Shue, F., Wang, N., Cheng, Y., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000550rr · Cited by 46
Liu, J., Wang, Z., Liang, W., Zhang, Z., Deng, Y., Chen, X., Hou, Z., Xie, Y., Wang, Q., Li, Y., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.018 · Cited by 56
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 48
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
Sinner, P., Peckert-Maier, K., Mohammadian, H., Kuhnt, C., Draßner, C., Panagiotakopoulou, V., Rauber, S., Linnerbauer, M., Haimon, Z., Royzman, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40370-2 · Cited by 47
Pesämaa, I., Müller, S. A., Robinson, S., Darcher, A., Paquet, D., Zetterberg, H., Lichtenthaler, S. F., & Haass, C. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00657-w · Cited by 40
“In TREM2 knock-out (ko) models, microglia are locked in a homeostatic state, while microglia from GRN ko models are hyperactivated [11, 12].”
BackgroundInfluentialSelf-citationSommer, D., Corstjens, I., Sanchez, S., Dooley, D., Lemmens, S., Broeckhoven, J. V., Bogie, J. F. J., Vanmierlo, T., Vidal, P. M., Rose‐John, S., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.02.032 · Cited by 44
“Apoptosis was induced by UV exposure at 254 nm for 15min followed by 1 h incubation (Mazaheri et al., 2017).”
TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain
Fruhwürth, S., Reinert, L. S., Öberg, C., Sakr, M., Henricsson, M., Zetterberg, H., & Paludan, S. R. (2023) · Science Advances · doi:10.1126/sciadv.adf5808 · Cited by 40
Feiten, A. F., Dahm, K., Schlepckow, K., van Lengerich, B., Suh, J. H., Reifschneider, A., Wefers, B., Bartos, L. M., Wind-Mark, K., de Weerd, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68706-8 · Cited by 39
“Variants of TREM2 are associated with increased risk for late-onset AD, and the paper aims to better understand the molecular and functional changes that occur in microglia when TREM2 is either upregulated or downregulated.”
Self-citationMultifaceted Involvement of Microglia in Gray Matter Pathology in Multiple Sclerosis
Tsouki, F., & Williams, A. (2021) · Stem Cells · doi:10.1002/stem.3374 · Cited by 41
Harnessing cerebral organoids for Alzheimer's disease research
Bubnys, A., & Tsai, L. (2021) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.10.003 · Cited by 44
Yan, Y., Bai, S., Han, H., Dai, J., Niu, L., Wang, H., Dong, Q., Yin, H., Yuan, G., & Pan, Y. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01642-6 · Cited by 49
“In the central nervous system, trem2 is closely associated with microglial phagocytosis, migration and activation [3].”
BackgroundMcKee, C., Hoffos, M., Vecchiarelli, H. A., & Tremblay, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1125982 · Cited by 40
“The binding of TREM2 ligands including Aβ, apolipoproteins, phospholipids, and lipopolysaccharides (Kober and Brett, 2017) activates DNAX-activating protein of 12 kDa (DAP12), TREM2’s binding partner, increasing microglial migration, lipid metabolism, autophagy, and phagocytosis, notably of myelin (Mazaheri et al., 20…”
BackgroundINPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
Iguchi, A., Takatori, S., Kimura, S., Muneto, H., Wang, K., Etani, H., Ito, G., Sato, H., Hori, Y., Sasaki, J., et al. (2023) · iScience · doi:10.1016/j.isci.2023.106375 · Cited by 42
He, G., Luo, Z., Shen, T., Wang, Z.-Z., Li, P., Luo, X. G., Yang, J., Tan, Y., Wang, Y., Gao, P., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00591 · Cited by 39
“Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate regulatory receptor of microglia that is linked to the inhibition of inflammatory responses and the potentiation of phagocytic effects in the CNS (Takahashi et al., 2005; Zhong et al., 2015; Xiang et al., 2016; Mazaheri et al., 2017).”
BackgroundHuang, Y., Guimarães, T. R., Todd, N., Ferguson, C., Weiss, K. M., Stauffer, F., McDermott, B., Hurtle, B. T., Saito, T., Saido, T. C., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204828119 · Cited by 38
Obst, J., Hall-Roberts, H. L., Smith, T. B., Kreuzer, M., Magno, L., Di Daniel, E., Davis, J. B., & Mead, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-96144-7 · Cited by 46
Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease
Nanjundaiah, S., Chidambaram, H., Chandrashekar, M., & Chinnathambi, S. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00883-6 · Cited by 36
Zhang, S.-S., Gao, Z., Feng, L., & Li, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s483412 · Cited by 40
Movers and shakers: Microglial dynamics and modulation of neural networks
Whitelaw, B. S., Stoessel, M. B., & Majewska, A. K. (2022) · Glia · doi:10.1002/glia.24323 · Cited by 35
“as TREM2 deficiency also impairs microglial chemotaxis, migration, and response to focal injury (Mazaheri et al., 2017), which could affect neuronal development independently of synaptic engulfment.”
BackgroundTREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophages
Chen, X., Zhao, Y., Huang, Y., Zhu, K., Zeng, F., Zhao, J., Zhang, H., Zhu, X., Kettenmann, H., & Xiang, X. (2023) · Glia · doi:10.1002/glia.24456 · Cited by 40
“…on myeloid cells 2 (TREM2) is exclusively expressed in the myeloid cell lineage, regulating important myeloid cell functions, including proliferation (Schlepckow et al., 2020), migration (Mazaheri et al., 2017), and phagocytosis (Hsieh et al., 2009; Kleinberger et al., 2014; Xiang et al., 2016).”
BackgroundEtxeberria, A., Shen, Y.-A. A., Vito, S., Silverman, S. M., Imperio, J., Lalehzadeh, G., Soung, A. L., Du, C., Xie, L., Choy, M. K., et al. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.2347-23.2024 · Cited by 35
The Primary Microglial Leukodystrophies: A Review
Ferrer, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116341 · Cited by 40
Pang, X., Chu, Y., Zhou, L., Chen, M., You, Y., Tang, Y., Yang, S., Zhang, H., Xiao, J., Deng, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15987 · Cited by 36
Falcón, C., Monté, G. C., Grau‐Rivera, O., Suárez‐Calvet, M., Sánchez‐Valle, R., Rami, L., Bosch, B., Haass, C., Gispert, J. D., & Molinuevo, J. L. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101801 · Cited by 40
“On the other hand, triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor involved in phagocytosis regulation, inflammatory signaling inhibition, and cell survival promotion that is selectively expressed by microglia in the central nervous system (Takahashi et al., 2005; Ulrich et al., 2…”
BackgroundSelf-citationKonishi, H., & Kiyama, H. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104878 · Cited by 35
PET imaging of microglia in Alzheimer's disease using copper-64 labeled TREM2 antibodies
Shojaei, M., Schaefer, R., Schlepckow, K., Kunze, L. H., Struebing, F. L., Brunner, B., Willem, M., Bartos, L. M., Feiten, A., Palumbo, G., et al. (2024) · Theranostics · doi:10.7150/thno.97149 · Cited by 36
“TREM2 is a type-1 transmembrane protein that plays an essential role in microglial functions [24, 25] and their transition from a homeostatic state to DAM [7, 11, 26, 27].”
BackgroundSelf-citationSteiner, A., Schlepckow, K., Brunner, B., Steiner, H., Haass, C., & Hagn, F. (2020) · The EMBO Journal · doi:10.15252/embj.2019104247 · Cited by 33
Self-citationErnest James Phillips, T., & Maguire, E. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.652593 · Cited by 33
“TREM2 is currently being investigated as a target for AD therapies (Long et al., 2019) and dysregulation of TREM2 has been shown to reduce chemotaxis (Mazaheri et al., 2017).”
BackgroundMicroglial TREM2 in amyotrophic lateral sclerosis
Xie, M., Zhao, S., Bosco, D. B., Nguyen, A. T., & Wu, L. (2021) · Developmental Neurobiology · doi:10.1002/dneu.22864 · Cited by 36
Defining Microglial States and Nomenclature: A Roadmap to 2030Preprint
Paolicelli, R. C., Sierra, A., Stevens, B., Tremblay, M., Aguzzi, A., Ajami, B., Amit, I., Audinat, É., Bechmann, I., Bennett, M. L., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4065080 · Cited by 33
Self-citationThe role of TREM2 N-glycans in trafficking to the cell surface and signal transduction of TREM2
Shirotani, K., Hatta, D., Wakita, N., Watanabe, K., & Iwata, N. (2022) · The Journal of Biochemistry · doi:10.1093/jb/mvac073 · Cited by 33
Lish, A. M., Ashour, N., Pearse, R. V., Galle, P. C., Orme, G. A., Heuer, S. E., Benoit, C. R., Alexander, K. D., Grogan, E. F. L., Terzioglu, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115777 · Cited by 36
“20,21 However, the field’s understanding of APOE and TREM2 in microglial states largely relies on mouse models, which limits our ability to discern species-specific differences and unravel the mechanisms of intercellular crosstalk that regulate human microglial activity.”
Gao, H., Di, J., Clausen, B. H., Wang, N., Zhu, X., Zhao, T., Chang, Y., Pang, M., Yang, Y., He, R., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112629 · Cited by 38
Tobeh, N. S., & Bruce, K. D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1259012 · Cited by 38
Depletion and activation of microglia impact metabolic connectivity of the mouse brain
Gnörich, J. S., Reifschneider, A., Wind-Mark, K., Zatcepin, A., Kunte, S. T., Beumers, P., Bartos, L. M., Wiedemann, T., Grosch, M., Xiang, X., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02735-8 · Cited by 37
“Trem2 deficient mice not only showed sustained but even increased expression of homeostatic genes compared to WT mice, leading to impaired activation and, therefore, locking mice in a resting state impairing a potential protective response in neurodegenerative conditions [40].”
BackgroundMethodSelf-citationRoles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 42
“TREM2 deficiency or dysfunction not only significantly impairs the overall migratory ability of microglia, but also causes directional migration defects, thereby reducing the response efficiency of microglia to pathological processes such as neuronal damage [8, 89].”
Yan, H., Wang, W., Cui, T., Shao, Y., Li, M., Fang, L., & Feng, L. (2024) · ImmunoTargets and Therapy · doi:10.2147/itt.s455881 · Cited by 33
Zhuang, X., Jie, L., Song, Y., Ban, R., Zhao, X., Xia, Z., Wang, Z., & Zhang, G. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08815-z · Cited by 35
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 34
“Lastly, the protein triggering receptor expressed on myeloid cells 2 (TREM2) is an immune receptor expressed by microglia which is upregulated in neuroinflammatory responses to neuronal injury [122].”
BackgroundThe Microglial Response to Neurodegenerative Disease
Song, W. M., & Colonna, M. (2018) · Advances in immunology · doi:10.1016/bs.ai.2018.04.002 · Cited by 30
Identity and nature of neural stem cells in the adult human subventricular zone
Baig, S., Nadaf, J., Allache, R., Le, P. U., Luo, M., Djedid, A., Nkili-Meyong, A. A., Safisamghabadi, M., Prat, A., Antel, J. P., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109342 · Cited by 33
“injury, neuroprotection, and degenerative pathologies (73, 74).”
Wang, L., Ouyang, D., Li, L., Cao, Y., Wang, Y., Gu, N., Zhang, Z., Zhao, L., Tang, S., Tang, H. D., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03337-2 · Cited by 37
“The loss of TREM2 function maintains microglia in a resting state [57].”
The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks
Constantino, N. J., Ashley, C. C., & Macauley, S. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70294 · Cited by 31
“…with FDG-PET uptake, implicating reactive microglia as a substantial source of cerebral glucose utilization (Xiang et al. 2021; Brendel et al. 2016; Choi et al. 2021; Krasemann et al. 2017; Keren-Shaul et al. 2017; Mazaheri et al. 2017; Brendel et al. 2017; Mirzaei et al. 2016; Liu et al. 2015).”
InfluentialReview: Molecular pathology of frontotemporal lobar degenerations
Borroni, B., Alberici, A., & Buratti, E. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12534 · Cited by 30
Essa, H., Peyton, L., Hasan, W., León, B. E., & Choi, D. (2022) · Cells · doi:10.3390/cells11020286 · Cited by 28
“have described that TREM2 deficiency impairs vital microglial functions, which tightly correlates with AD and neurodegenerative diseases progression [20].”
BackgroundFatty acids as biomodulators of Piezo1 mediated glial mechanosensitivity in Alzheimer's disease
Ivković, S., Major, T., Mitić, M., Lončarević‐Vasiljković, N., Jović, M., & Adžić, M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120470 · Cited by 29
Astroglial and microglial pathology in Down syndrome: Focus on Alzheimer's disease
García, O., & Aguilar, L. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.987212 · Cited by 26
“Triggering receptor expressed on myeloid cells 2 is involved in microglial phagocytosis (Krasemann et al., 2017; Mazaheri et al., 2017), and its serum and plasma levels are increased in young adults with DS (Raha-Chowdhury et al.”
BackgroundHassan, H., Rawlinson, C., Lan, Y., Jenkins, S. I., & Chen, R. (2025) · Biomolecules · doi:10.3390/biom15111629 · Cited by 34
“Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) plays a crucial role in the non-inflammatory clearance of apoptotic neurons and is essential for microglial chemotaxis in response to neuronal injury [33–36].”
Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer’s Disease
Yahaya, M. A. F., Zolkiffly, S. Z. I., Moklas, M. A. M., Hamid, H. A., Stanslas, J., Zainol, M., & Mehat, M. Z. (2020) · Journal of Immunology Research · doi:10.1155/2020/9469210 · Cited by 25
“The classical activation undergone by microglial cells will cause the cells to phenotypically transform into M1-like macrophages which is analogous to the polarisation of T-helper 1 (Th1) [23, 24].”
The role of microglia in prion diseases and possible therapeutic targets: a literature review
de Melo, A. S. L. F., Lima, J. L. D., Malta, M. C., Marroquim, N. F., Moreira, Á. R., Ladeia, I. D. A., Cardoso, F. D. S., Gonçalves, D. B., Dutra, B. G., & dos Santos, J. C. C. (2021) · Prion · doi:10.1080/19336896.2021.1991771 · Cited by 27
“susceptibility[45], with the polymorphism encoding”
BackgroundZhao, J., Ren, T., Li, X., Guo, T.-L., Liu, C., & Wang, X. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.831977 · Cited by 24
“In AD, the ability of microglia to prune Aβ plaques has been found to be impaired, changes in the plaque compaction occur, the levels of neurotoxic oligomic Aβ as well as fibrous Aβ increase, thus leading to neuronal malnutrition and death (Mazaheri et al., 2017).”
BackgroundShi, J., & Huang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010016 · Cited by 23
“DAM cluster around A β plaques, while a TREM2 deficiency impairs such clustering and exacerbates the AD pathology, as demonstrated in mouse models [80,81].”
Backgroundvon Saucken, V. E., Jay, T. R., & Landreth, G. E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105072 · Cited by 23
Li, X., Tang, X., Zeng, J., Duan, L., Hou, Z., Li, L., Guo, Y., Chai, C., Liu, J., Wang, Y., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.020 · Cited by 32
Microglial Transforming Growth Factor-β Signaling in Alzheimer’s Disease
Vidovic, N., & Spittau, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063090 · Cited by 25
“A lack of TREM2 was speculated to lock microglia in a homeostatic state, thereby blocking the defense mechanisms during AD progression [147].”
BackgroundCurrent understanding on TREM-2 molecular biology and physiopathological functions
Bharadwaj, S., Groza, Y., Mierzwicka, J. M., & Malý, P. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112042 · Cited by 25
Strategies and Tools for Studying Microglial-Mediated Synapse Elimination and Refinement
Morini, R., Bizzotto, M., Perrucci, F., Filipello, F., & Matteoli, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640937 · Cited by 26
Characterization of gene expression profiles in the mouse brain after 35 days of spaceflight mission
Holley, J. M., Stanbouly, S., Pecaut, M. J., Willey, J. S., Delp, M. D., & Mao, X. W. (2022) · npj Microgravity · doi:10.1038/s41526-022-00217-4 · Cited by 24
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Rao, Y., & Peng, B. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.02.025 · Cited by 20
“…mutations located at the extracellular domain (such as D87N, R62H, T96K and R47H) cause defective binding to its ligands, including A 𝛽 and various lipoproteins, resulting in the weakening of microglial A 𝛽 response, survival, proliferation and other neuroprotective functions [ 26 , 55 , 56 ].”
BackgroundCSF glial biomarkers are associated with cognition in individuals at risk of Alzheimer's disease
Warmenhoven, N., Sánchez‐Benavides, G., González‐Escalante, A., Milà‐Alomà, M., Shekari, M., López‐Martos, D., Ortiz‐Romero, P., Kollmorgen, G., Quijano‐Rubio, C., Minguillón, C., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13862 · Cited by 25
Sulforaphane Attenuates Aβ Oligomers Mediated Decrease in Phagocytic Activity of Microglial Cells
Chilakala, R. R., Manchikalapudi, A. L., Kumar, A., & Sunkaria, A. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.002 · Cited by 21
TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
Lee-Gosselin, A., Jury-Garfe, N., You, Y., Dabin, L., Soni, D., Dutta, S., Rochet, J.-C., Kim, J., Oblak, A. L., & Lasagna-Reeves, C. A. (2023) · Cells · doi:10.3390/cells12121597 · Cited by 23
“Trem2-mediated signaling is known to inhibit the transition of microglia to a more Disease-Associated Microglia (DAM) state characterized by enhanced migration, chemotaxis, and phagocytosis [44,45].”
BackgroundThe Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
The versatile role of TREM2 in regulating of microglia fate in the ischemic stroke
Ma, W.-Y., Wang, S., Wu, Q.-L., Zhou, X., Chu, S., & Chen, N. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108733 · Cited by 22
The Innate and Adaptive Immune Cells in Alzheimer’s and Parkinson’s Diseases
Huang, B., Zhenxin, Y., Chen, S., Tan, Z., Zong, Z., Zhang, H., & Xiong, X. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1315248 · Cited by 23
Basha, S. C., Ramaiah, M. J., & Rao, K. S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221070 · Cited by 24
“The functional role of TREM2 is diverse ranging from chemotaxis, dead cells engulfment [60], phagocytosis of A fibrils, and energy metabolism maintenance [61].”
BackgroundBonomi, C. G., Assogna, M., Donna, M. G. D., Bernocchi, F., Lucia, V. D., Nuccetelli, M., Fiorelli, D., Loizzo, S., Mercuri, N. B., Koch, G., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221010 · Cited by 23
Metadata
- Authors
- Mazaheri, F., Snaidero, N., Kleinberger, G., Madore, C., Daria, A., Werner, G., Krasemann, S., Capell, A., Trümbach, D., Wurst, W., Brunner, B., Bultmann, S., Tahirovic, S., Kerschensteiner, M., Misgeld, T., Butovsky, O., & Haass, C.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- LMU Klinikum (DE)
- Munich Cluster for Systems Neurology (DE)
- Brigham and Women's Hospital (US)
- Ludwig-Maximilians-Universität München (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Helmholtz Munich (DE)
- Center for Integrated Protein Science Munich (DE)
- Corresponding author
- Haass, Christian
- ORCID
- Venue
- The EMBO Reports
- Published
- 2017-05-08
- Volume
- 18
- Issue
- 7
- Pages
- 1186-1198
- ISSN
- 1469-221X (ISSN-L)
- 1469-3178
- PMC
- PMC5494532
- OpenAlex
- W2612288104
- Cited by
- 351
- References
- 69
- Citations by year
- 2026: 37 · 2025: 34 · 2024: 39 · 2023: 35 · 2022: 40 · 2021: 41 · 2020: 44 · 2019: 34 · 2018: 36 · 2017: 10
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- EMBO Reports (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- DZNE Pub (submittedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (EXC 1010, Mi 694/4‐1(SPP1710)/7‐1/8‐1)
- European Union's Seventh Framework Program (FP7/2007–2013)
- ERC (321366, 616791)
- Cure Alzheimer's
- Center for Integrated Protein Science Munich (EXC 114)
- Hans‐and‐Ilse‐Breuer Foundation
- German Science Foundation Collaborative Research Centre (870)
- Helmholtz Portfolio Theme “Supercomputing and Modeling for the Human Brain”
- NIH‐NINDS (1R01NS088137)
- NIA (1R01AG051812)
- National Multiple Sclerosis Society (5092A1)
- Amyotrophic Lateral Sclerosis Association (ALSA2087)
- Nancy Davis Foundation
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, microglia, chemotaxis, microglial migration, neuronal injury, loss of function, microglial transcriptome, Alzheimer's disease, frontotemporal lobar degeneration, somatosensory cortex, neurodegeneration
- MeSH terms
- Loss of Function Mutation, Alzheimer Disease, Cells, Cultured, Chemotaxis, Humans, Membrane Glycoproteins, Neurons, Phagocytosis, Receptors, Immunologic, Microglia, Neurodegenerative Diseases, Gene Expression Profiling, Myeloid Cells, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.